Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes

por Jamwal, Rohitash, Barlock, Benjamin J.
Publicado 2020

Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse model

por Iannucci, Jaclyn, Johnson, Shelby L., Majchrzak, Mark, Barlock, Benjamin J., Akhlaghi, Fatemeh, Seeram, Navindra P., Sen, Abhik, Grammas, Paula
Publicado 2020

Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer’s Disease and Related Disorders

por Hill, Jaunetta, Shalaby, Karim E., Bihaqi, Syed W., Alansi, Bothaina H., Barlock, Benjamin, Parang, Keykavous, Thompson, Richard, Ouararhni, Khalid, Zawia, Nasser H.
Publicado 2023

Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets

por DaSilva, Nicholas A., Barlock, Benjamin J., Guha, Prajna, Ghosh, Chandra C., Trebino, Catherine E., Camberg, Jodi L., Katz, Steven C., Rowley, David C.
Publicado 2021